WESTFIELD CAPITAL MANAGEMENT CO LP

Holdings History for Ascendis Pharma A/S - American Depositary Shares (ASND)

Symbol: ASND on Nasdaq
Investment type: Equity - Shares of Stock
Class: American Depositary Shares
Latest Disclosed Ownership: 5.53M shares
Security Ownership: 9.18%

Shares, Excluding Options vs Price

Value, Excluding Options

Westfield Capital Management Company, L.P. ownership in Ascendis Pharma A/S American Depositary Shares (ASND)

2025-02-11 - Westfield Capital Management Company, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.53M shares of Ascendis Pharma A/S American Depositary Shares (ASND). This represents 9.18% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Westfield Capital Management Company, L.P.	9.18%		$831M	5.53M			$150.31	13G/A	12/31/2024	11 Feb 2025 09:15:25
Westfield Capital Management Company, L.P.	9.18%		$613M	4.08M			$150.31	13G/A	12/31/2024	10 Feb 2025 17:13:33

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	3.31%	+0.24%	$761M	5.53M	+394,473	+7.68%	$137.67	Q4 2024
9/30/2024	3.46%	+0.12%	$767M	5.13M	+170,942	+3.44%	$149.31	Q3 2024
6/30/2024	3.33%	+0.64%	$677M	4.96M	+887,610	+21.8%	$136.38	Q2 2024
3/31/2024	3.23%	+0.04%	$616M	4.08M	+44,580	+1.11%	$151.17	Q1 2024
12/31/2023	2.96%	+0.2%	$508M	4.03M	+228,457	+6.01%	$125.95	Q4 2023
9/30/2023	2.43%	+0.11%	$356M	3.8M	+170,465	+4.69%	$93.64	Q3 2023
6/30/2023	2.06%	+0.28%	$324M	3.63M	+485,586	+15.4%	$89.25	Q2 2023
3/31/2023	2.38%	-0.01%	$337M	3.15M	-12,042	-0.38%	$107.22	Q1 2023
12/31/2022	2.98%	+0.23%	$386M	3.16M	+247,444	+8.5%	$122.13	Q4 2022
9/30/2022	2.39%	+0.1%	$301M	2.91M	+122,415	+4.39%	$103.26	Q3 2022
6/30/2022	2.04%	+0.11%	$259M	2.79M	+153,282	+5.82%	$92.96	Q2 2022
3/31/2022	1.98%	0%	$309M	2.64M	-5,907	-0.22%	$117.36	Q1 2022
12/31/2021	2.11%	+0.42%	$355M	2.64M	+529,441	+25.1%	$134.53	Q4 2021
9/30/2021	2.03%	+0.09%	$337M	2.11M	+95,566	+4.74%	$159.39	Q3 2021
6/30/2021	1.59%	+0.12%	$265M	2.02M	+148,234	+7.94%	$131.55	Q2 2021
3/31/2021	1.5%	+0.11%	$241M	1.87M	+137,812	+7.97%	$128.88	Q1 2021
12/31/2020	1.71%	-0.06%	$289M	1.73M	-59,893	-3.35%	$166.78	Q4 2020
9/30/2020	1.79%	+0.35%	$276M	1.79M	+351,109	+24.4%	$154.32	Q3 2020
6/30/2020	1.46%	+0.08%	$213M	1.44M	+75,323	+5.52%	$147.90	Q2 2020
3/31/2020	1.35%	+0.1%	$154M	1.36M	+102,586	+8.14%	$112.61	Q1 2020
12/31/2019	1.25%	+0.14%	$175M	1.26M	+136,702	+12.2%	$139.12	Q4 2019
9/30/2019	0.87%	+0.12%	$108M	1.12M	+152,302	+15.7%	$96.32	Q3 2019
6/30/2019	0.84%	+0.25%	$112M	972K	+285,207	+41.5%	$115.15	Q2 2019
3/31/2019	0.61%	+0.13%	$80.8M	687K	+147,425	+27.3%	$117.70	Q1 2019
12/31/2018	0.29%	-0.02%	$33.8M	539K	-42,614	-7.33%	$62.65	Q4 2018
9/30/2018	0.29%	+0.08%	$41.2M	582K	+157,159	+37%	$70.86	Q3 2018
6/30/2018	0.21%	+0.21%	$28.2M	425K	+424,575	NEW	$66.52	Q2 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.